- Home
- VSTE vs DTIL Comparison
VSTE vs DTIL Comparison
Compare VSTE & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- DTIL
- Stock Information
- Founded
- VSTE 2009
- DTIL 2006
- Country
- VSTE Australia
- DTIL United States
- Employees
- VSTE N/A
- DTIL N/A
- Industry
- VSTE
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- DTIL Health Care
- Exchange
- VSTE Nasdaq
- DTIL Nasdaq
- Market Cap
- VSTE 51.9M
- DTIL 44.1M
- IPO Year
- VSTE N/A
- DTIL 2019
- Fundamental
- Price
- VSTE $1.22
- DTIL $4.74
- Analyst Decision
- VSTE
- DTIL Strong Buy
- Analyst Count
- VSTE 0
- DTIL 2
- Target Price
- VSTE N/A
- DTIL $39.50
- AVG Volume (30 Days)
- VSTE 3.8M
- DTIL 138.8K
- Earning Date
- VSTE 01-01-0001
- DTIL 11-04-2024
- Dividend Yield
- VSTE N/A
- DTIL N/A
- EPS Growth
- VSTE N/A
- DTIL N/A
- EPS
- VSTE N/A
- DTIL 1.45
- Revenue
- VSTE $342,000.00
- DTIL $75,096,000.00
- Revenue This Year
- VSTE N/A
- DTIL $50.33
- Revenue Next Year
- VSTE N/A
- DTIL N/A
- P/E Ratio
- VSTE N/A
- DTIL $3.25
- Revenue Growth
- VSTE N/A
- DTIL 43.62
- 52 Week Low
- VSTE $0.83
- DTIL $4.13
- 52 Week High
- VSTE $11.99
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- VSTE 43.67
- DTIL 37.70
- Support Level
- VSTE $1.12
- DTIL $4.45
- Resistance Level
- VSTE $1.32
- DTIL $5.01
- Average True Range (ATR)
- VSTE 0.21
- DTIL 0.46
- MACD
- VSTE -0.01
- DTIL 0.03
- Stochastic Oscillator
- VSTE 10.33
- DTIL 37.41
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.